JL Marenco

  • Citations Per Year
Learn More
We report the case of a patient with Behçet's disease who presented with deep vein thrombosis and pulmonary embolism. In spite of being treated initially with anticoagulants, corticosteroid and oral cyclophosphamide, the patient presented again with a new pulmonary embolism. This critical situation made us initiate thrombolytic therapy with a urokinase(More)
INTRODUCTION Patients with systemic lupus erythematosus (SLE) have increased cardiovascular risk related to lipid changes induced by inflammatory activity, proteinuria and treatments. Our objective was to analyse lipid changes in a cohort of patients with SLE resistant to standard treatments who were treated with rituximab. METHODS The study population(More)
Material and methods This is an observational, retrospective and multicenter study. Sequential observation was made at baseline, at 24 week and final visit. The outcome variables were: clinic improvement measured by SLEDAI, Physician’s Global Assessment (PGA) and patient hospitalization for SLE during the 24 week and final visit. Statistical analysis of the(More)
Patients and methods -Patient 1: A 43 years-old woman developed progressive cough and dyspnea, with radiological changes of interstitial lung disease. She began treatment with oral glucocorticoids and monthly boluses of CYC (1g i.v). -Patient 2: A 53 years-old woman with a diagnosis of diffuse scleroderma three years earlier, started with dyspnea during low(More)
Material and methods We have reviewed all RA patients treated with biologicals from 1998 to January 2010. We include all patients with at least 6 months of follow up and analyze clinical efficacy as improvement in DAS count. We registered the cause for switch among biologic drugs and the response to a new biologic. Our hospital attends about 350.000(More)
Introduction Granulomatosis with poliangeitis (Wegener) is a necrotizing granulomatous vasculitis characterized by damage in the respiratory tract, kidney, skin, nervous system ... The onset of the disease is usually indolent, with nonspecific symptoms. The most frequent initial clinical presentation is the upper respiratory tract involvement (90%). The(More)